Latest: FDA Approves New Biosimilar for Oncology Treatment

Abemaciclib/Endocrine Therapy Improves OS in HR+/HER2– Early Breast Cancer

by Cancer Network

14 September, 2025

0 Mins

Results from the monarchE study showed a statistically significant OS improvement with abemaciclib plus ET for patients with HR+/HER2– early breast cancer.

Tags:

Author

Cancer Network

How Stress Impacts Sleep (and What You Can Do About It)

STAT+: Inside the CDC director’s ouster: Kennedy demanded acceptance of new vaccine policies; Susan Monarez refused

📢

300x250 Banner

Abemaciclib/Endocrine Therapy Improves OS in HR+/HER2– Early Breast Cancer

Tags:

Cancer Network

How Stress Impacts Sleep (and What You Can Do About It)

STAT+: Inside the CDC director’s ouster: Kennedy demanded acceptance of new vaccine policies; Susan Monarez refused

Recent Content

COPD Biologics: Early Treatment Insights

Antihypertensive Medication Guidelines

Juvenile Arthritis Care Transition